According to Ovid Therapeutics 's latest financial reports the company's current EPS (TTM) is -$0.70. In 2022 the company made an earnings per share (EPS) of -$0.77 a decrease over its 2021 EPS that were of $1.77.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.70 | -9.09% |
2022 | -$0.77 | -143.5% |
2021 | $1.77 | -226.43% |
2020 | -$1.40 | -11.39% |
2019 | -$1.58 | -25.47% |
2018 | -$2.12 | -23.94% |
2017 | -$2.79 | 143.74% |
2016 | -$1.14 |